Corporate Banner
Satellite Banner
Mass Spectrometry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

908 Devices Introduces World’s First Handheld Mass Spectrometer

Published: Tuesday, March 11, 2014
Last Updated: Tuesday, March 11, 2014
Bookmark and Share
M908 uses patented high-pressure mass spectrometry to enhance detection and identification capabilities for first responders.

908 Devices has introduced M908™, the world’s first truly handheld tool utilizing high-pressure mass spectrometry™ (HPMS). Specifically engineered for civilian users, first responders, and military teams, M908 provides accurate, immediate detection and identification of trace level chemical and explosive hazards at the point-of-action.

Conventional mass spectrometers (MS) are typically confined to centralized laboratories by their large size, fragility and complexity of operation and maintenance.

Early efforts at shrinking MS lead to luggable mass spec systems however, these instruments remain large and fragile resulting in limited deployment.

908 Devices is the first to deliver MS capability in a truly rugged and handheld form factor dramatically expanding first responder capabilities. Unlike any other MS, M908 weighs less than 2kg (4.4 lbs) and is battery powered for continuous operation in the field.

It has been designed to meet commercial and military standards (MIL-STD-810G); which require repeated drops onto concrete and metal, storage and operation in extreme hot and cold conditions, and ingress protection to dust and water.

The patented HPMS technology which powers M908 uses diminutive ion traps that measure less than a millimeter in diameter and that are capable of operation at 10,000 times higher pressure than those in conventional MS systems. This enables the use of small, rugged vacuum pumps, micro ionizers, detectors and efficient electronics.

“At 908 Devices we believe in solving specific problems, creating unique tools rather than general purpose instruments that do anything - but nothing quite that well. M908 is our first fit-for-purpose product line built on this philosophy,” says Dr. Kevin J. Knopp, co-founder and chief executive officer at 908 Devices. “We have received a very positive initial response to M908 and look forward to even broader applications with the technology.”

At the core of HPMS is seminal intellectual property of micro mass spectrometry developed by 908 Devices’ Science Founder, Dr. J. Michael Ramsey; the Minnie N. Goldby Distinguished Professor of Chemistry at the University of North Carolina, Chapel Hill.

The research conducted by Ramsey’s group on micro MS began at Oak Ridge National Labs and continued at UNC. This is an on-going program that has invested $17.5M in support from DOE, DARPA, and DTRA.

This HPMS technology has already been recognized by the scientific community, winning The Analytical Scientist Innovation Award in 2013 and demonstrating the impact that small, simple and robust mass spec devices will have.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

908 Devices Announces Significant Milestones
Company has expanded its office from a 7,000 square-foot R&D think tank into a 16,000 square-foot full-scale production facility.
Wednesday, August 20, 2014
908 Devices Receives $7 Million in Series B Funding
The financing round will be used to expand the R&D team and to accelerate and commercialize 908 Devices’ initial safety and security products.
Wednesday, September 11, 2013
908 Devices’ Research Partner Presents Research on Mass Spectrometry
Advancing the rapidly evolving field of High Pressure Mass Spectrometry.
Friday, August 16, 2013
Scientific News
Getting a Better Look at How HIV Infects and Takes Over its Host Cells
A new approach, developed by a team of researchers led by The Rockefeller University and The Aaron Diamond AIDS Research Center (ADARC), offers an unprecedented view of how a virus infects and appropriates a host cell, step by step.
Detecting Fake Parmesan Cheeses
Scientists report on a way to catch adulteration of the regional artisanal products.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Process Analysis in Real Time
With a real-time mass spectrometer developed by Fraunhofer researchers, it has become possible for the first time to analyze up to 30 components simultaneously from the gas phase and a liquid, including in-situ analysis.
Triple-Negative Breast Cancer Target Is Found
Researchers at UC Berkeley discover a target that drives cancer metabolism in triple-negative breast cancer.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
A Mechanistic Tool for Studying Fungal Pathogens
This study presents an overview of lipid extraction, chromatographic separation and mass spectrometry employed in qualitative and quantitative sphingolipidomics in fungi.
Newborn Screening Test Developed For Rare, Deadly Neurological Disorder
Scientists have developed a new dried blood spot screening test for Niemann-Pick type C, with goal to speed diagnosis and treatment.
HIV Particles Used to Trap Intact Mammalian Protein Complexes
Belgian scientists from VIB and UGent developed Virotrap, a viral particle sorting approach for purifying protein complexes under native conditions.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!